36 Results for "

azd2

" in MedChemExpress (MCE) Product Catalog:
Products (36)

36 Results for "azd2" in MCE Product Catalog:

375
375 Publications Verification
Cat. No.: HY-10162
CAS No.: 763113-22-0
Purity:  99.98%
Synonyms: azd2281; KU0059436
Target:  

PARP Autophagy Mitophagy

Research Areas:  

Cancer

Olaparib (AZD2281; KU0059436) is a potent and orally active PARP inhibitor with IC50s of 5 and 1 nM for PARP1 and PARP2, respectively. Olaparib is an autophagy and mitophagy activator. Olaparib cannot cross the intact blood-brain barrier (BBB) .
loading...
    loading...
31
31 Cited Publications
Cat. No.: HY-15247
CAS No.: 1009298-59-2
Purity:  99.32%
Synonyms: azd2014
Target:  

mTOR Autophagy Apoptosis

Research Areas:  

Cancer

Vistusertib (AZD2014) is an ATP competitive mTOR inhibitor with an IC50 of 2.81 nM. AZD2014 inhibits both mTORC1 and mTORC2 complexes.
loading...
    loading...
14
14 Cited Publications
Cat. No.: HY-10205
CAS No.: 288383-20-0
Purity:  99.87%
Synonyms: azd2171
Cediranib (AZD2171) is a highly potent, orally available and blood-brain barrier permeability VEGFR tyrosine kinase inhibitor with IC50s of <1, <3, 5, 5, 36, 2 nM for Flt1, KDR, Flt4, PDGFRα, PDGFRβ, c-Kit, respectively.
loading...
    loading...
14
14 Cited Publications
Cat. No.: HY-13049
CAS No.: 857036-77-2
Purity:  99.95%
Synonyms: azd-2171 maleate
Target:  

VEGFR Autophagy PDGFR

Research Areas:  

Cancer

Cediranib maleate (AZD-2171 maleate) is a highly potent, orally available VEGFR inhibitor with IC50s of <1, <3, 5, 5, 36, 2 nM for Flt1, KDR, Flt4, PDGFRα, PDGFRβ, c-Kit, respectively.
loading...
    loading...
10
10 Cited Publications
Cat. No.: HY-13536
CAS No.: 1174043-16-3
Purity:  99.79%
Target:  

PARP

Research Areas:  

Cancer

AZD-2461 is a potent PARP inhibitor, with IC50s of 5 nM, 2 nM and 200 nM for PARP1, PARP2 and PARP3, respectively.
loading...
    loading...
9
9 Cited Publications
Cat. No.: HY-10126
CAS No.: 722544-51-6
Purity:  99.47%
Synonyms: azd2811; INH-34; azd1152-HQPA
Target:  

Aurora Kinase Apoptosis

Research Areas:  

Cancer

Barasertib-HQPA (AZD2811) is a highly selective Aurora B inhibitor with an IC50 of 0.37 nM in a cell-free assay. Barasertib-HQPA (AZD2811) induces growth arrest and apoptosis in cancer cells .
loading...
    loading...
9
9 Cited Publications
Cat. No.: HY-15761
CAS No.: 486424-20-8
Purity:  98.42%
Target:  

GSK-3

Research Areas:  

Neurological Disease

AZD2858 is a potent, orally active GSK-3 inhibitor, with IC50s of 0.9 and 5 nM for GSK-3α and GSK-3β, respectively, used in the research of fracture healing.
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-U00064
CAS No.: 566203-88-1
Target:  

CCR

AZD2098 is a potent and selective CC-chemokine receptor 4 (CCR4) inhibitor with pIC50s of 7.8, 8.0, 8.0 and 7.6 for human, rat, mouse and dog respectively, used for asthma research .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-14432
CAS No.: 941690-55-7
Purity:  99.83%
Synonyms: MLE-4901; azd2624; azd4901
Target:  

Neurokinin Receptor

Research Areas:  

Neurological Disease Endocrinology

Pavinetant (MLE-4901) is a neurokinin-3 receptor (NK3R) antagonist.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-10162R
CAS No.: 763113-22-0
Synonyms: azd2281 (Standard); KU0059436 (Standard)
Research Areas:  

Cancer

Olaparib (Standard) is the analytical standard of Olaparib. This product is intended for research and analytical applications. Olaparib (AZD2281; KU0059436) is a potent and orally active PARP inhibitor with IC50s of 5 and 1 nM for PARP1 and PARP2, respectively. Olaparib is an autophagy and mitophagy activator .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-113854
CAS No.: 1034148-15-6
Purity:  99.90%
AZD2906 is a selective glucocorticoid receptor (GR) agonist, increases micronucleated immature erythrocytes in the bone marrow of rats. AZD2906 shows IC50s of 2.2, 0.3, 41.6 and 7.5 nM at GR in human, rat PBMC and human, rat whole blood, respectively .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-110255
CAS No.: 934282-55-0
Purity:  99.8%
Research Areas:  

Neurological Disease

AZD-2066 is a selective, orally active and blood-brain barrier-permeating mGluR5 antagonist. AZD 2066 activates the BDNF/trkB signaling pathway. AZD 2066 can be used in the research of neuropathic pain, major depressive disorder and gastroesophageal reflux disease .
loading...
    loading...
Cat. No.: HY-172317
CAS No.: 2791472-12-1
Target:  

FAP

Research Areas:  

Metabolic Disease

AZD2389 is a potent and orally active FAP inhibitor. AZD2389 can be used for the study of metabolic dysfunction-associated steatohepatitis .
loading...
    loading...
Cat. No.: HY-135891
CAS No.: 1229603-37-5
Purity:  99.91%
Target:  

CCR

Research Areas:  

Neurological Disease

AZD2423 is a potent, selective, orally bioavailable, and non-competitive CCR2 chemokine receptor negative allosteric modulator. AZD2423 has an IC50 of 1.2 nM for CCR2 Ca 2+ flux .
loading...
    loading...
Cat. No.: HY-10162S
CAS No.: 2143107-56-4
Purity:  ≥99.0%
Synonyms: azd2281-d5; KU0059436-d5
Olaparib-d5 (AZD2281-d5) is the deuterium labeled Olaparib (HY-10162). Olaparib is a potent and orally active PARP inhibitor with IC50s of 5 and 1 nM for PARP1 and PARP2, respectively. Olaparib is an autophagy and mitophagy activator .
loading...
    loading...
Cat. No.: HY-P990704
CAS No.: 2640305-01-5
Synonyms: azd-2936

Research Areas:  

Cancer

Rilvegostomig (AZD-2936) is a bispecific humanized IgG1 antibody targeting PD-1 and TIGIT. Rilvegostomig induces tumor growth inhibition and modulates the tumor immune microenvironment. Rilvegostomig exhibits anti-tumor activity in metastatic non-small cell lung cancer (without prior immune checkpoint inhibitor treatment). Rilvegostomig can be used in research related to metastatic non-small cell lung cancer and endometrial cancer .
loading...
    loading...
Cat. No.: HY-10162S1
Purity:  99.57%
Synonyms: azd2281-d8; KU0059436-d8
Olaparib-d8 (AZD2281-d8) is the deuterium labeled Olaparib (HY-10162). Olaparib is a potent and orally active PARP inhibitor with IC50s of 5 and 1 nM for PARP1 and PARP2, respectively. Olaparib is an autophagy and mitophagy activator .
loading...
    loading...
Cat. No.: HY-120078
CAS No.: 1845753-81-2
Target:  

Phospholipase

Research Areas:  

Cardiovascular Disease

AZD2716 is an orally active secretory phospholipase A2 (sPLA2) inhibitor. AZD2716 inhibits human GIIA sPLA2 (IC50=10 nM), human GV sPLA2 (IC50=40 nM), human GX sPLA2 (IC50=400 nM), snake venom sPLA2 (IC50=2 pM), and snake (Bothrops jararacussu) Lys49-PLA2-like toxin (Kd=110 μM). AZD2716 inhibits sPLA2 isoforms IIa, V, X, snake venom sPLA2s, and snake venom Lys49-PLA2-like toxin myotoxic activity via hydrophobic channel binding. AZD2716 suppresses GIIA sPLA2 production, neutralizes snake venom-induced myotoxicity, and improves survival in envenomed mice. AZD2716 can be used for the research of coronary artery disease, atherosclerosis, and snakebite envenoming .
loading...
    loading...
Cat. No.: HY-18179
CAS No.: 883986-34-3
Target:  

PDGFR VEGFR FLT3 c-Kit

Research Areas:  

Cancer

AZD2932 is a potent and multi-targeted kinase inhibitor VEGFR2, PDGFβ, Flt-3 and c-Kit with IC50s of 8, 4, 7 and 9 nM in cell assay, respectively.
loading...
    loading...
Cat. No.: HY-177653A
CAS No.: 2639854-33-2
Synonyms: azd2373 sodium, ION-972190 sodium
Target:  

Apolipoprotein

Research Areas:  

Metabolic Disease

Opemalirsen sodium is an antisense oligonucleotide targeted to apolipoprotein L1 (APOL1). It is used for the study of Kidney disorders.
loading...
    loading...